You just read:

Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases

News provided by

Ascletis Pharma Inc.

Jan 13, 2019, 19:30 ET